Proteomics & biofarmaceutische eiwitproductie en delivery-technologieën.

Protein Technologies Ghent is a consortium of research groups from UGent and VIB, each with a long-standing reputation of expertise in their respective fields.

Centered around facilitating biopharmaceutical moiety discovery and development, the consortium integrates the assembled know-how from its members to accelerate the process of developing novel therapies against e.g. viral infections, microbial antibiotics resistance and cancer.